-
In this issue: Dementia and benzodiazepines; effectiveness of omega-3 fatty acid and Ginkgo biloba supplements; and FDA actions.
-
In discussing birth control options with a patient, she tells you she is interested in taking the Pill, but is concerned that it might be dangerous due to all the risks. Whats your next move?
-
Get ready to add new information to your contraceptive clinical dataset.
-
Unscheduled spotting and bleeding occurs in 30% to 50% of women in the first few months of combined oral contraceptive (OC) use.1 How can you help patients stay the course?
-
One of the clearest outcomes of the 2012 election is that the Affordable Care Act (ACA), better known as Obamacare, has survived the last major threat to its existence.
-
An annual Pap smear might soon become a thing of the past. Most women should be screened for cervical cancer no more often than once every three to five years, according to new cervical cancer screening guidance issued by the American College of Obstetricians and Gynecologists (ACOG).
-
Public health is a familiar setting for many readers of Contraceptive Technology Update. About 51% of respondents to the 2012 Salary Survey say they work in a health department, and most noted no changes in 2012 staffing numbers.
-
Emergency contraception (EC) should be widely available and easily accessible to all women, according to a just-released committee opinion issued by the American College of Obstetricians and Gynecologists (ACOG).
-
In 1992, reproductive health advocates estimated that widespread use of emergency contraceptive pills (ECPs) could prevent half of all U.S. unintended pregnancies and abortions.
-